2. HYPOCALCEMIA
Children – is defined as a total serum calcium
concentration less than 2.1 mmol/L (8.5
mg/dL).
Term infants -less than 2 mmol/L (8 mg/dL) or
ionized fraction of less than 1.1 mmol/L (4.4
mg/dL)
Pre term -less than 1.75 mmol/L (7 mg/dL)
5. Epidemiology
Late onset hypoglycemia –common (developing
countries)
Age related demographics -:
-Mostly new borns
-older children : associated with
#critical illness
#acquired hypoparathyroidism
#mutations in calcium – sensing receptor
#defect in Vit.D supply or metabolism
7. Etiology
• In neonates :
Early onset neonatal hypocalcemia
Late onset neonatal hypocalcemia
• In infants and children :
Hypoparathyroidism,
Abnormal vitamin d production or action, and
Hyperphosphatemia
10. Lab . Findings
• Total and ionized serum calcium
levels
• Serum magnesium levels
• Serum electrolyte and glucose levels
• Phosphorus levels
• Parathormone levels
• Vitamin D metabolite (25-
hydroxyvitamin D and 1,25-
dihydroxyvitamin D) levels
• Urine calcium, magnesium,
phosphorus, and creatinine levels
• Serum alkaline phosphatase levels
11. Additional tests:
• Malabsorption workup
• Total lymphocyte and T-cell
subset analyses
• Chest radiography
• Ankle and wrist radiography
• Electrocardiography
• Karyotyping
12. Management
1 ml of Ca.gluconate (10%) -9 mg elemental ca.
EARLY NEOANTAL HYPOCALCEMIA:
Patients at increased risk of hypocalcemia
Patients diagnosed –asymptomatic
Patients diagnosed – symptomatic
13. Patients at increased risk of hypocalcemia
• -pre term + sick (DM) + perinatal asphyxia
= 40 mg/kg/day
• -infants (oral feeds)
calcium PO=q.6 hrly
• -therapy – continued ---3 days
21. NURSING MANAGEMENT
• Assessment
• Identify the infants at risk
• Administer supp. Ca, vit .D, phos.
• Monitor during infusion
• Nutritional supplementation
22. DIAGNOSIS
• Risk for injury r/t seizures secondary to
hypocalcemia
• Ineffective airway clearance r/t laryngospasm
sec. to hypocalcemia
• Impaired skin integrity r/t infiltration of
calcium infusion
• Ineffective perfusion r/t rapid infusion of
calcium
27. Management (medical)
• Should not be treated with Ca.or Vit.D
• Mg. salts ----can be given
• 50% solution of MgSO4, 0.005 to 0.1 mL/kg
(0.1 to 0.2 mmol/kg or 2.5 to 5.0 mg / kg )
slow IV 30-60 MIN
……..Repeated doses-q 8-12 hrs
28. • Concominant oral Mg suppl
• if Mal absorption- 1mg/kg/day PO (daily)
• Serum Mg. conc. Measured
• Oral MgSO4 --- are not well absorbed---
diarrhoea
• Well titrated
33. DEFINITION:
Neonatal Hypoglycemia is defined as a plasma
glucose level of less than mg/dL ( mmol/L) in
the first 24 hrs of life and less than 45 mg/dL
(2.5 mmol/L) .
34. INCIDENCE
• Differs ----population, method & timing of
feeding
• Early feeding ------decreases incidence
• IBM :
CHO metabolism disorders(>1:10,000)
Fatty acid oxidation disorders(1:10,000)
Hereditary fructose intolerance (1:20,000/50…)
Glycogen storage diseases(1:25,000)
Galactosemia
46. ----with BS levels < 20 mg/dL
-after 1 hr of starting IV fluids & then q hr
----BS <40 mg/dL-(even after 1 hr of oral feeds)
- q 6h for 48 hrs
47. To calculate rate of glucose
administration
• % glucose x mL/kg/d = glucose infusion rate
(mg/kg/min)
144
Or
• % glucose x mL/h = glucose infusion
rate (mg/kg/min)
• 6 x body weight (kg)
48. Asymptomatic hypoglycemia
• Are at risk for neurodevelopment
• Initially feed---BM/ formula---spoon or gavage
• Check BS-----30-60 min-before next feed
• If >45mg/dL---2-3 hrly feed ---q 4-6 hr monitor
for 48hrs
49. • IV Infusion if :
BS < 25 mg/dL
BS remains <45 mg/dL
Enteral feed –contra..
Baby becomes –sympt..
50. Symptomatic hypoglycemia
• Can result in high incidence ----neural inj.
• Bolus 2mL/kg –10%D—IV
• Following –IV dextrose (6mg/kg/min)
• BS –rechecked—after 15-30 min
• If BS 45 mg/dL ---hrly ---for 4-6 hrly
• If BS- remains < 45 mg/dL
GIR---increased 2mg/kg/min q 15-30
min… (+) checked
51. • Tappering glucose infusion –
Once BS values >45 mg/dL stabilized 24 hrs
infusion is tappered.
Infusion is tappered @ 2mg/kg/min-q 6hrs
Oral feeds ca be started if not
contraindicated
53. Nursing Diagnosis
• Risk for complications related to lower plasma
glucose levels such as mental disorders,
behavioral disorders, autonomic nerve
function disorders, hypoglycemic coma